This MiniReview reports the current knowledge about the treatment of arterial hypertension
with the third‐generation beta‐adrenoceptor antagonist (BAA) nebivolol. Furthermore, it …

Background The exact sequence of events leading to ultimate hepatocellular damage
following ischemia/reperfusion (I/R) is incompletely understood. In this article, we review a …

The vascular endothelium is a critical determinant of diabetes-associated vascular
complications, and improving endothelial function is an important target for therapy …

A number of studies have reported that acute lung injury (ALI) and acute respiratory distress
syndrome (ARDS) are independent risk factors for organ dysfunction and mortality in …

Background Information Atherosclerosis is an inflammatory disease, in which risk factors
such as hyperlipidemia and hypertension affect the arterial endothelium, resulting in …

The aim of the present study was to examine the effects of obesity alone and obesity
associated with Type 2 diabetes on the structure, vascular reactivity and response to insulin …

This review provides a systematic overview of the influence of the third generation beta-
adrenoceptor antagonists on vascular and/or endothelial function at a cellular level as well …

Diabetes mellitus is one of the most common metabolic diseases in the world and the
vascular dysfunction represents a challenging clinical problem. In diabetes, endothelial cells …

Nebivolol is a highly selective β 1-adrenoceptor blocker, which also stimulates endothelial
nitric oxide synthase and scavenges reactive oxygen species (ROS). These characteristics …

Circulating microparticles (MPs) and endothelial progenitor cells (EPCs) correlate with
endothelial dysfunction and contribute to the pathogenesis of atherosclerosis. In this context …